General Medicine Haematology Strong — NICE NG89 Recommended
Padua Prediction Score (VTE Risk)
Assesses VTE risk in medical inpatients to guide pharmacological thromboprophylaxis.
References
- Barbar S et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism. J Thromb Haemost. 2010.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Enoxaparin (LMWH) · Anticoagulant
- Thiamine (IV/IM — Pabrinex) · Vitamin B1 (Thiamine) — deficiency treatment / Wernicke's encephalopathy prevention
- Anthrax Vaccine · Vaccine (Bacterial — Anthrax Prevention)
- Edoxaban (AF Stroke Prevention / VTE) · Direct Factor Xa Inhibitor (DOAC)
- Enoxaparin · Low Molecular Weight Heparin (LMWH)
- Enoxaparin sodium · Low molecular weight heparin (LMWH)
Pathways
- Sepsis Screening and Sepsis Six · UK Sepsis Trust; NICE NG51; Surviving Sepsis Campaign 2021
- Unintentional Weight Loss Workup · NICE NG12; BSG
- Chronic Fatigue Workup · NICE NG206; BMJ Best Practice
- Lymphadenopathy Workup · NICE NG12; BMJ Best Practice
- Pre-op Medical Clearance · NICE NG45; ESC 2022
- Secondary Hypertension Workup · NICE NG136; ESH 2023
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.